About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in Austin | 73 Studies

Clinical Trials Pancreatic CancerAustin

Pancreatic Cancer Clinical Trials in Austin

Find 73 clinical trials for pancreatic cancer near Austin, Texas. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in Austin

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 61-73 of 73 trials

TerminatedA Dose Escalation/Expansion Study of MDK-703 in Patients With Advanced or Metastatic Solid TumorsThis is an open-label, dose escalation and dose expansion study of MDK-703 as a monotherapy and in combination with other cancer therapies in adult study participants with…NCT05716295·Sarasota, Florida and 5 others Active not recruitingEvaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid TumorsThe objective of this study is to evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects with Advanced or Metastatic Solid Tumors.NCT07021066·Scottsdale, Arizona and 10 others CompletedDNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)The primary objective of this study, DELFI-L101, is to train and test classifiers for lung cancer detection using the DELFI assay and other biomarker and clinical features.NCT04825834·Homewood, Alabama and 56 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedPhase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC PatientsThis is a Phase 2, multicenter, open-label, 3-arm, randomized, parallel group study to evaluate the efficacy and safety of TTX-030 with or without budigalimab in combination with…NCT06119217·Tucson, Arizona and 63 others

RecruitingStudy to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab AdizutecanCancer is a condition where cells in a specific part of body grow and reproduce uncontrollably.NCT05005403·Duarte, California and 47 others

RecruitingAtebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic AdenocarcinomaThe purpose of this study is to evaluate the safety and efficacy of atebimetinib in combination with modified GnP compared with SOC GnP alone.NCT07562152·Huntsville, Alabama and 50 others

Active not recruitingStudy of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid TumorsStudy of NGM831 as Monotherapy and in Combination with Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid TumorsNCT05215574·Gilbert, Arizona and 8 others

TerminatedNiraparib in the Treatment of Patients With Advanced PALB2 Mutated TumorsThe purpose of this study is to further evaluate the efficacy and safety of niraparib in patients with locally advanced or metastatic solid tumors and a pathogenic or likely…NCT05169437·Yuma, Arizona and 79 others

TerminatedA Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell TumorsThis study randomized patients with advanced pancreatic islet cell tumors to receive either sunitinib or placebo.NCT00428597·Aurora, Colorado and 53 others

CompletedStudy of SBP-101 in Pancreatic CancerThis phase 1 first-in-human study evaluates safety and tolerability of SBP-101 in subjects with previously treated pancreatic ductal adenocarcinoma and will identify the maximum…NCT02657330·Scottsdale, Arizona and 3 others

RecruitingThis is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid TumorsThis is a phase 1 dose escalation trial of ZM008, an anti-LLT1 antibody as a single agent followed by combination with Toripalimab in patients with advanced solid tumors who have…NCT06451497·Boston, Massachusetts and 2 others

TerminatedGV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic CancerTo investigate the efficacy of GV1001 in sequential combination with gemcitabine in locally advanced and metastatic adenocarcinoma of the pancreas.NCT00358566·Mobile, Alabama and 85 others

UnknownA Phase I Study of WM-S1-030 in Patients With Advanced Solid TumorsThis study evaluates the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of WM-S1-030 in patients with advanced solid tumors.NCT04801095·Clayton, Victoria and 5 others

PreviousPage 4 of 4

Other Conditions in Austin

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia